{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T02:00:45Z","timestamp":1706925645314},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00393-022-01282-6","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T16:03:44Z","timestamp":1667577824000},"page":"851-857","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nierenmanifestationen bei Vaskulitiden kleiner und mittelgro\u00dfer Gef\u00e4\u00dfe"],"prefix":"10.1007","volume":"81","author":[{"given":"Johanna","family":"Schneider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Venhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"key":"1282_CR1","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1681\/ASN.2010050477","volume":"21","author":"AE Berden","year":"2010","unstructured":"Berden\u00a0AE, Ferrario\u00a0F, Hagen\u00a0EC et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J\u00a0Am Soc Nephrol 21:1628\u20131636","journal-title":"J Am Soc Nephrol"},{"key":"1282_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1053\/j.gastro.2018.04.024","volume":"155","author":"M Bonacci","year":"2018","unstructured":"Bonacci\u00a0M, Lens\u00a0S, Marino\u00a0Z et al (2018) Long-term outcomes of patients with HCV-associated cryoglobulinemic vasculitis after virologic cure. Gastroenterology 155:311\u2013315.e6","journal-title":"Gastroenterology"},{"key":"1282_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","volume":"57","author":"JC Brouet","year":"1974","unstructured":"Brouet\u00a0JC, Clauvel\u00a0JP, Danon\u00a0F et\u00a0al (1974) Biologic and clinical significance of cryoglobulins. A report of 86\u00a0cases. Am J Med 57:775\u2013788","journal-title":"Am J Med"},{"key":"1282_CR4","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung\u00a0SA, Langford\u00a0CA, Maz\u00a0M et al (2021) 2021 American college of rheumatology\/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol 73:1366\u20131383","journal-title":"Arthritis Rheumatol"},{"key":"1282_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12882-022-02689-8","volume":"23","author":"A Corthier","year":"2022","unstructured":"Corthier\u00a0A, Jachiet\u00a0M, Bertin\u00a0D et al (2022) Biopsy-proven kidney involvement in hypocomplementemic urticarial vasculitis. BMC Nephrol 23:67","journal-title":"BMC Nephrol"},{"key":"1282_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00808-1","author":"F Dammacco","year":"2022","unstructured":"Dammacco\u00a0F, Lauletta\u00a0G, Vacca\u00a0A (2022) The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements. Clin Exp Med. https:\/\/doi.org\/10.1007\/s10238-022-00808-1","journal-title":"Clin Exp Med"},{"key":"1282_CR7","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1093\/ndt\/12.9.1874","volume":"12","author":"K El-Reshaid","year":"1997","unstructured":"El-Reshaid\u00a0K, Kapoor\u00a0MM, El-Reshaid\u00a0W et al (1997) The spectrum of renal disease associated with microscopic polyangiitis and classic polyarteritis nodosa in Kuwait. Nephrol Dial Transplant 12:1874\u20131882","journal-title":"Nephrol Dial Transplant"},{"key":"1282_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann\u00a0O, Berden\u00a0A, de Groot\u00a0K et al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70:488\u2013494","journal-title":"Ann Rheum Dis"},{"key":"1282_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","volume":"44","author":"M Gayraud","year":"2001","unstructured":"Gayraud\u00a0M, Guillevin\u00a0L, le Toumelin\u00a0P et al (2001) Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278\u00a0patients. Arthritis Rheum 44:666\u2013675","journal-title":"Arthritis Rheum"},{"key":"1282_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5415\/apallergy.2014.4.1.42","volume":"4","author":"R Ghrahani","year":"2014","unstructured":"Ghrahani\u00a0R, Ledika\u00a0MA, Sapartini\u00a0G et al (2014) Age of onset as a\u00a0risk factor of renal involvement in Henoch-Schonlein purpura. Asia Pac Allergy 4:42\u201347","journal-title":"Asia Pac Allergy"},{"key":"1282_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/TP.0000000000000910","volume":"100","author":"A Goceroglu","year":"2016","unstructured":"Goceroglu\u00a0A, Rahmattulla\u00a0C, Berden\u00a0AE et al (2016) The Dutch transplantation in vasculitis (DUTRAVAS) study: outcome of renal transplantation in antineutrophil cytoplasmic antibody-associated glomerulonephritis. Transplantation 100:916\u2013924","journal-title":"Transplantation"},{"key":"1282_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin\u00a0L, Pagnoux\u00a0C, Seror\u00a0R et al (2011) The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French vasculitis study group (FVSG) cohort. Medicine 90:19\u201327","journal-title":"Medicine"},{"key":"1282_CR13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ki.2010.558","volume":"79","author":"SM Hamour","year":"2011","unstructured":"Hamour\u00a0SM, Salama\u00a0AD (2011) ANCA comes of age-but with caveats. Kidney Int 79:699\u2013701","journal-title":"Kidney Int"},{"key":"1282_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/TP.0b013e3181c9cc4a","volume":"89","author":"SS Han","year":"2010","unstructured":"Han\u00a0SS, Sun\u00a0HK, Lee\u00a0JP et al (2010) Outcome of renal allograft in patients with Henoch-Schonlein nephritis: single-center experience and systematic review. Transplantation 89:721\u2013726","journal-title":"Transplantation"},{"key":"1282_CR15","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink\u00a0HJL, Stefansson\u00a0BV, Correa-Rotter\u00a0R et al (2020) Dapagliflozin in patients with chronic kidney disease. N\u00a0Engl J Med 383:1436\u20131446","journal-title":"N Engl J Med"},{"key":"1282_CR16","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1681\/ASN.2014090903","volume":"26","author":"M Hilhorst","year":"2015","unstructured":"Hilhorst\u00a0M, van Paassen\u00a0P, Tervaert\u00a0JW et al (2015) Proteinase 3\u2011ANCA vasculitis versus myeloperoxidase-ANCA vasculitis. J\u00a0Am Soc Nephrol 26:2314\u20132327","journal-title":"J Am Soc Nephrol"},{"key":"1282_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1053\/j.ajkd.2015.03.025","volume":"66","author":"Z Hruskova","year":"2015","unstructured":"Hruskova\u00a0Z, Stel\u00a0VS, Jayne\u00a0D et al (2015) Characteristics and outcomes of granulomatosis with polyangiitis (Wegener) and microscopic polyangiitis requiring renal replacement therapy: results from the European renal association-European dialysis and transplant association registry. Am J Kidney Dis 66:613\u2013620","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"1282_CR18","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3390\/jcm9072131","volume":"9","author":"O Ion","year":"2020","unstructured":"Ion\u00a0O, Obrisca\u00a0B, Ismail\u00a0G et al (2020) Kidney involvement in hypocomplementemic urticarial vasculitis syndrome\u2014a case-based review. J\u00a0Clin Med 9(7):2131","journal-title":"J Clin Med"},{"key":"1282_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/art.38956","volume":"67","author":"M Jachiet","year":"2015","unstructured":"Jachiet\u00a0M, Flageul\u00a0B, Deroux\u00a0A et al (2015) The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a\u00a0French nationwide study of fifty-seven patients. Arthritis Rheumatol 67:527\u2013534","journal-title":"Arthritis Rheumatol"},{"key":"1282_CR20","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DR Jayne","year":"2007","unstructured":"Jayne\u00a0DR, Gaskin\u00a0G, Rasmussen\u00a0N et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J\u00a0Am Soc Nephrol 18:2180\u20132188","journal-title":"J Am Soc Nephrol"},{"key":"1282_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne\u00a0DRW, Merkel\u00a0PA, Schall\u00a0TJ et al (2021) Avacopan for the treatment of ANCA-associated vasculitis. N\u00a0Engl J Med 384:599\u2013609","journal-title":"N Engl J Med"},{"key":"1282_CR22","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","volume":"63","author":"JC Jennette","year":"2003","unstructured":"Jennette\u00a0JC (2003) Rapidly progressive crescentic glomerulonephritis. Kidney Int 63:1164\u20131177","journal-title":"Kidney Int"},{"key":"1282_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette\u00a0JC, Falk\u00a0RJ, Bacon\u00a0PA et\u00a0al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"1282_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00005792-198507000-00003","volume":"64","author":"JP Johnson","year":"1985","unstructured":"Johnson\u00a0JP, Moore\u00a0J Jr., Austin\u00a0HA 3rd et al (1985) Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine 64:219\u2013227","journal-title":"Medicine"},{"key":"1282_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones\u00a0RB, Tervaert\u00a0JW, Hauser\u00a0T et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N\u00a0Engl J Med 363:211\u2013220","journal-title":"N Engl J Med"},{"key":"1282_CR26","volume-title":"Glomerular diseases. Kidney disease: improving global outcome","author":"Kdigo","year":"2021","unstructured":"Kdigo (2021) Glomerular diseases. Kidney disease: improving global outcome"},{"key":"1282_CR27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","volume":"134","author":"JB Levy","year":"2001","unstructured":"Levy\u00a0JB, Turner\u00a0AN, Rees\u00a0AJ et al (2001) Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134:1033\u20131042","journal-title":"Ann Intern Med"},{"key":"1282_CR28","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/ki.2009.218","volume":"76","author":"S Lionaki","year":"2009","unstructured":"Lionaki\u00a0S, Hogan\u00a0SL, Jennette\u00a0CE et al (2009) The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney Int 76:644\u2013651","journal-title":"Kidney Int"},{"key":"1282_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.40339","volume":"70","author":"F Maritati","year":"2018","unstructured":"Maritati\u00a0F, Fenoglio\u00a0R, Pillebout\u00a0E et al (2018) Brief report: rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schonlein). Arthritis Rheumatol 70:109\u2013114","journal-title":"Arthritis Rheumatol"},{"key":"1282_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/ndt\/gfx378","volume":"34","author":"SP Mcadoo","year":"2019","unstructured":"Mcadoo\u00a0SP, Medjeral-Thomas\u00a0N, Gopaluni\u00a0S et al (2019) Long-term follow-up of a\u00a0combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis. Nephrol Dial Transplant 34:63\u201373","journal-title":"Nephrol Dial Transplant"},{"key":"1282_CR31","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1002\/art.24957","volume":"60","author":"MD Morgan","year":"2009","unstructured":"Morgan\u00a0MD, Turnbull\u00a0J, Selamet\u00a0U et al (2009) Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a\u00a0matched-pair cohort study. Arthritis Rheum 60:3493\u20133500","journal-title":"Arthritis Rheum"},{"key":"1282_CR32","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan\u00a0P, Pierce\u00a0SB, Segel\u00a0R et\u00a0al (2014) Mutant adenosine deaminase 2 in a\u00a0polyarteritis nodosa vasculopathy. N\u00a0Engl J Med 370:921\u2013931","journal-title":"N Engl J Med"},{"key":"1282_CR33","volume-title":"Uptodate","author":"PA Niaudet","year":"2022","unstructured":"Niaudet\u00a0PA et al (2022) IgA vasculitis (Henoch-Sch\u00f6nlein purpura): kidney manifestations. In: Lam\u00a0AQ (Hrsg) Uptodate"},{"key":"1282_CR34","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.ekir.2019.07.021","volume":"4","author":"A Nikolopoulou","year":"2019","unstructured":"Nikolopoulou\u00a0A, Huang-Doran\u00a0I, Mcadoo\u00a0SP et al (2019) Membranous glomerulonephritis with crescents. Kidney Int Rep 4:1577\u20131584","journal-title":"Kidney Int Rep"},{"key":"1282_CR35","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","volume":"43","author":"E Reinhold-Keller","year":"2000","unstructured":"Reinhold-Keller\u00a0E, Beuge\u00a0N, Latza\u00a0U et al (2000) An interdisciplinary approach to the care of patients with Wegener\u2019s granulomatosis: long-term outcome in 155\u00a0patients. Arthritis Rheum 43:1021\u20131032","journal-title":"Arthritis Rheum"},{"key":"1282_CR36","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1053\/ajkd.2002.33385","volume":"39","author":"AD Salama","year":"2002","unstructured":"Salama\u00a0AD, Dougan\u00a0T, Levy\u00a0JB et al (2002) Goodpasture\u2019s disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis 39:1162\u20131167","journal-title":"Am J Kidney Dis"},{"key":"1282_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00393-022-01161-0","volume":"81","author":"C Specker","year":"2022","unstructured":"Specker\u00a0C, Passens\u00a0D, Schlaak\u00a0J (2022) Cryoglobulinemic vasculitis. Z\u00a0Rheumatol 81:300\u2013304","journal-title":"Z Rheumatol"},{"key":"1282_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone\u00a0JH, Merkel\u00a0PA, Spiera\u00a0R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N\u00a0Engl J Med 363:221\u2013232","journal-title":"N Engl J Med"},{"key":"1282_CR39","doi-asserted-by":"publisher","first-page":"e064604","DOI":"10.1136\/bmj-2021-064604","volume":"376","author":"M Walsh","year":"2022","unstructured":"Walsh\u00a0M, Collister\u00a0D, Zeng\u00a0L et al (2022) The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis. BMJ 376:e64604","journal-title":"BMJ"},{"key":"1282_CR40","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh\u00a0M, Merkel\u00a0PA, Peh\u00a0CA et al (2020) Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N\u00a0Engl J Med 382:622\u2013631","journal-title":"N Engl J Med"},{"key":"1282_CR41","doi-asserted-by":"publisher","first-page":"e064597","DOI":"10.1136\/bmj-2021-064597","volume":"376","author":"L Zeng","year":"2022","unstructured":"Zeng\u00a0L, Walsh\u00a0M, Guyatt\u00a0GH et al (2022) Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a\u00a0clinical practice guideline. BMJ 376:e64597","journal-title":"BMJ"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01282-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-022-01282-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01282-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T12:05:54Z","timestamp":1670501154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-022-01282-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1282"],"URL":"https:\/\/doi.org\/10.1007\/s00393-022-01282-6","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"27 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"N. Venhoff: Vortragshonorare: Roche, GSK, Vifor. Beraterhonorare: GSK, Vifor. J.\u00a0Schneider gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}